Home ➤ Life Science ➤ Diagnostics ➤ Point-of-Care Molecular Diagnostics Market
Point-of-Care Molecular Diagnostics Market
Published date: Apr 2024 • Formats:
[email protected] +1 718 874 1545
Request Sample Schedule a Call

Point-of-Care Molecular Diagnostics Market Analysis By Technology (PCR-based, Hybridization-based, Genetic Sequencing-based, Microarray-based), By Application (Oncology, Hematology, Infectious Diseases, Prenatal Testing, Other Applications), By Test Location (OTC, POC), By End-use (Hospitals, Home-care, Decentralized Labs , Research Institutes, Other End-Uses), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Apr 2024
  • Report ID: 117982
  • Number of Pages: 359
  • Format:
Fact Checked
Point-of-Care Molecular Diagnostics Market https://market.us/report/point-of-care-molecular-diagnostics-market/
Cite this Research
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Point-of-Care Molecular Diagnostics Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Point-of-Care Molecular Diagnostics Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Point-of-Care Molecular Diagnostics Market Analysis and Forecast, By Segment, 2018-2033
      • 3.1. Key Findings
      • 3.2. Global Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Product, 2018-2033
      • 3.3. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
        • 3.3.1. PCR-based
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Hybridization-based
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Genetic Sequencing-based
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Microarray-based
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
      • 3.4. Global Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Application, 2018-2033
      • 3.5. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
        • 3.5.1. Infectious Diseases
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Oncology
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Hematology
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Prenatal Testing
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Other Applications
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
      • 3.6. Global Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Test Location, 2018-2033
      • 3.7. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
        • 3.7.1. OTC
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. POC
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
      • 3.8. Global Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-Use, 2018-2033
      • 3.9. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
        • 3.9.1. Hospitals
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Home-care
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Decentralized Labs
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
        • 3.9.4. Research Institutes
          • 3.9.4.1. Insights
          • 3.9.4.2. Key Takeaways
        • 3.9.5. Other End-Uses
          • 3.9.5.1. Insights
          • 3.9.5.2. Key Takeaways
    • 4. Global Point-of-Care Molecular Diagnostics Market Analysis and Forecast, By Region, 2018-2033
      • 4.1. Key Findings
      • 4.2. Global Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Region, 2018-2033
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Region
    • 5. North America Point-of-Care Molecular Diagnostics Market Analysis and Forecast, 2018-2033
      • 5.1. Key Findings
      • 5.2. North America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Product, 2018-2033
      • 5.3. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 5.4. North America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Application, 2018-2033
      • 5.5. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 5.6. North America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Test Location, 2018-2033
      • 5.7. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • 5.8. North America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-Use, 2018-2033
      • 5.9. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • 5.10. North America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2018-2033
      • 5.11. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Point-of-Care Molecular Diagnostics Market Analysis and Forecast, 2018-2033
      • 6.1. Key Findings
      • 6.2. Europe Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Product, 2018-2033
      • 6.3. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 6.4. Europe Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Application, 2018-2033
      • 6.5. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 6.6. Europe Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Test Location, 2018-2033
      • 6.7. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • 6.8. Europe Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-Use, 2018-2033
      • 6.9. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • 6.10. Europe Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2018-2033
      • 6.11. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherlands
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis and Forecast, 2018-2033
      • 7.1. Key Findings
      • 7.2. Asia Pacific Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Product, 2018-2033
      • 7.3. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 7.4. Asia Pacific Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Application, 2018-2033
      • 7.5. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 7.6. Asia Pacific Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Test Location, 2018-2033
      • 7.7. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • 7.8. Asia Pacific Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-Use, 2018-2033
      • 7.9. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • 7.10. Asia Pacific Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2018-2033
      • 7.11. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. New Zealand
        • 7.11.6. Singapore
        • 7.11.7. Thailand
        • 7.11.8. Vietnam
        • 7.11.9. Rest of Asia Pacific
    • 8. Latin America Point-of-Care Molecular Diagnostics Market Analysis and Forecast, 2018-2033
      • 8.1. Key Findings
      • 8.2. Latin America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Product, 2018-2033
      • 8.3. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 8.4. Latin America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Application, 2018-2033
      • 8.5. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 8.6. Latin America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Test Location, 2018-2033
      • 8.7. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • 8.8. Latin America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-Use, 2018-2033
      • 8.9. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • 8.10. Latin America Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2018-2033
      • 8.11. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Point-of-Care Molecular Diagnostics Market Analysis and Forecast, 2018-2033
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Product, 2018-2033
      • 9.3. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 9.4. Middle East & Africa Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Application, 2018-2033
      • 9.5. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 9.6. Middle East & Africa Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Test Location, 2018-2033
      • 9.7. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • 9.8. Middle East & Africa Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By End-Use, 2018-2033
      • 9.9. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • 9.10. Middle East & Africa Point-of-Care Molecular Diagnostics Market Size Value (US$ Bn) Analysis, Opportunity and Forecast, By Country, 2018-2033
      • 9.11. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. F. Hoffmann-La Roche AG
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Abbott Laboratories
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. QIAGEN AV
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Bayer AG
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Nova Biomedical
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Danaher
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Nipro Diagnostics
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Bio-Rad Laboratories, Inc.
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Agilent Technologies, Inc.
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. bioMérieux
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. OraSure Technologies
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Test Location Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Test Location Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 2. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 3. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 4. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 5. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Region, 2018-2033
      • Table 6. North America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 7. North America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 8. North America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 9. North America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 10. North America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Country, 2018-2033
      • Table 11. The US Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 12. The US Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 13. The US Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 14. The US Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 15. Canada Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 16. Canada Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 17. Canada Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 18. Canada Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 19. Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 20. Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 21. Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 22. Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 23. Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Country, 2018-2033
      • Table 24. Germany Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 25. Germany Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 26. Germany Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 27. Germany Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 28. The UK Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 29. The UK Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 30. The UK Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 31. The UK Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 32. France Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 33. France Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 34. France Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 35. France Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 36. Spain Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 37. Spain Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 38. Spain Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 39. Spain Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 40. Italy Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 41. Italy Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 42. Italy Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 43. Italy Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 44. Russia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 45. Russia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 46. Russia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 47. Russia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 48. Netherlands Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 49. Netherlands Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 50. Netherlands Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 51. Netherlands Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 52. Rest of Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 53. Rest of Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 54. Rest of Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 55. Rest of Europe Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 56. Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 57. Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 58. Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 59. Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 60. Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Country, 2018-2033
      • Table 61. China Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 62. China Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 63. China Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 64. China Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 65. India Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 66. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 67. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 68. Global Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 69. Japan Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 70. Japan Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 71. Japan Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 72. Japan Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 73. South Korea Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 74. South Korea Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 75. South Korea Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 76. South Korea Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 77. New Zealand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 78. New Zealand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 79. New Zealand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 80. New Zealand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 81. Singapore Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 82. Singapore Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 83. Singapore Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 84. Singapore Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 85. Thailand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 86. Thailand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 87. Thailand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 88. Thailand Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 89. Vietnam Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 90. Vietnam Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 91. Vietnam Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 92. Vietnam Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 93. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 94. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 95. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 96. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 97. Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 98. Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 99. Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 100. Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 101. Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Country, 2018-2033
      • Table 102. Brazil Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 103. Brazil Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 104. Brazil Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 105. Brazil Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 106. Mexico Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 107. Mexico Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 108. Mexico Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 109. Mexico Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 110. Rest of Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 111. Rest of Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 112. Rest of Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 113. Rest of Latin America Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 114. Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 115. Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 116. Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 117. Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 118. Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Country, 2018-2033
      • Table 119. South Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 120. South Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 121. South Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 122. South Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 123. Saudi Arabia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 124. Saudi Arabia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 125. Saudi Arabia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 126. Saudi Arabia Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 127. UAE Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 128. UAE Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 129. UAE Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 130. UAE Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
      • Table 131. Rest of Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Product, 2018-2033
      • Table 132. Rest of Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2018-2033
      • Table 133. Rest of Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By Test Location, 2018-2033
      • Table 134. Rest of Middle East & Africa Point-of-Care Molecular Diagnostics Market Value (US$ Bn), By End-Use, 2018-2033
    • List of Figures
      • Figure 1. Global Point-of-Care Molecular Diagnostics Market Snapshot: Market Value (US$ Bn), 2018-2033
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Point-of-Care Molecular Diagnostics Market
      • Figure 5. Global Point-of-Care Molecular Diagnostics Market Analysis, By Product, 2018, 2022 and 2033
      • Figure 6. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 7. Global Point-of-Care Molecular Diagnostics Market Analysis, By Application, 2018, 2022 and 2033
      • Figure 8. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 9. Global Point-of-Care Molecular Diagnostics Market Analysis, By Test Location, 2018, 2022 and 2033
      • Figure 10. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • Figure 11. Global Point-of-Care Molecular Diagnostics Market Analysis, By End-Use, 2018, 2022 and 2033
      • Figure 12. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • Figure 13. North America Point-of-Care Molecular Diagnostics Market Analysis, By Product, 2018, 2022 and 2033
      • Figure 14. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 15. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by PCR-based, 2018-2033
      • Figure 16. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hybridization-based, 2018-2033
      • Figure 17. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Genetic Sequencing-based, 2018-2033
      • Figure 18. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Microarray-based, 2018-2033
      • Figure 19. North America Point-of-Care Molecular Diagnostics Market Analysis, By Application, 2018, 2022 and 2033
      • Figure 20. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 21. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Infectious Diseases, 2018-2033
      • Figure 22. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Oncology, 2018-2033
      • Figure 23. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hematology, 2018-2033
      • Figure 24. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Prenatal Testing, 2018-2033
      • Figure 25. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other Applications, 2018-2033
      • Figure 26. North America Point-of-Care Molecular Diagnostics Market Analysis, By Test Location, 2018, 2022 and 2033
      • Figure 27. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • Figure 28. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by OTC, 2018-2033
      • Figure 29. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by POC, 2018-2033
      • Figure 30. North America Point-of-Care Molecular Diagnostics Market Analysis, By End-Use, 2018, 2022 and 2033
      • Figure 31. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • Figure 32. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hospitals, 2018-2033
      • Figure 33. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Home-care, 2018-2033
      • Figure 34. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Decentralized Labs, 2018-2033
      • Figure 35. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Research Institutes, 2018-2033
      • Figure 36. North America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other End-Uses, 2018-2033
      • Figure 37. North America Point-of-Care Molecular Diagnostics Market Analysis, By Country, 2018, 2022 and 2033
      • Figure 38. North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 39. Europe Point-of-Care Molecular Diagnostics Market Analysis, By Product, 2018, 2022 and 2033
      • Figure 40. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 41. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by PCR-based, 2018-2033
      • Figure 42. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hybridization-based, 2018-2033
      • Figure 43. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Genetic Sequencing-based, 2018-2033
      • Figure 44. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Microarray-based, 2018-2033
      • Figure 45. Europe Point-of-Care Molecular Diagnostics Market Analysis, By Application, 2018, 2022 and 2033
      • Figure 46. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 47. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Infectious Diseases, 2018-2033
      • Figure 48. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Oncology, 2018-2033
      • Figure 49. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hematology, 2018-2033
      • Figure 50. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Prenatal Testing, 2018-2033
      • Figure 51. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other Applications, 2018-2033
      • Figure 52. Europe Point-of-Care Molecular Diagnostics Market Analysis, By Test Location, 2018, 2022 and 2033
      • Figure 53. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • Figure 54. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by OTC, 2018-2033
      • Figure 55. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by POC, 2018-2033
      • Figure 56. Europe Point-of-Care Molecular Diagnostics Market Analysis, By End-Use, 2018, 2022 and 2033
      • Figure 57. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • Figure 58. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hospitals, 2018-2033
      • Figure 59. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Home-care, 2018-2033
      • Figure 60. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Decentralized Labs, 2018-2033
      • Figure 61. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Research Institutes, 2018-2033
      • Figure 62. Europe Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other End-Uses, 2018-2033
      • Figure 63. Europe Point-of-Care Molecular Diagnostics Market Analysis, By Country, 2018, 2022 and 2033
      • Figure 64. Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 65. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis, By Product, 2018, 2022 and 2033
      • Figure 66. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 67. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by PCR-based, 2018-2033
      • Figure 68. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hybridization-based, 2018-2033
      • Figure 69. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Genetic Sequencing-based, 2018-2033
      • Figure 70. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Microarray-based, 2018-2033
      • Figure 71. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis, By Application, 2018, 2022 and 2033
      • Figure 72. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 73. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Infectious Diseases, 2018-2033
      • Figure 74. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Oncology, 2018-2033
      • Figure 75. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hematology, 2018-2033
      • Figure 76. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Prenatal Testing, 2018-2033
      • Figure 77. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other Applications, 2018-2033
      • Figure 78. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis, By Test Location, 2018, 2022 and 2033
      • Figure 79. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • Figure 80. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by OTC, 2018-2033
      • Figure 81. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by POC, 2018-2033
      • Figure 82. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis, By End-Use, 2018, 2022 and 2033
      • Figure 83. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • Figure 84. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hospitals, 2018-2033
      • Figure 85. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Home-care, 2018-2033
      • Figure 86. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Decentralized Labs, 2018-2033
      • Figure 87. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Research Institutes, 2018-2033
      • Figure 88. Asia Pacific Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other End-Uses, 2018-2033
      • Figure 89. Asia Pacific Point-of-Care Molecular Diagnostics Market Analysis, By Country, 2018, 2022 and 2033
      • Figure 90. Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 91. Latin America Point-of-Care Molecular Diagnostics Market Analysis, By Product, 2018, 2022 and 2033
      • Figure 92. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 93. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by PCR-based, 2018-2033
      • Figure 94. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hybridization-based, 2018-2033
      • Figure 95. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Genetic Sequencing-based, 2018-2033
      • Figure 96. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Microarray-based, 2018-2033
      • Figure 97. Latin America Point-of-Care Molecular Diagnostics Market Analysis, By Application, 2018, 2022 and 2033
      • Figure 98. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 99. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Infectious Diseases, 2018-2033
      • Figure 100. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Oncology, 2018-2033
      • Figure 101. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hematology, 2018-2033
      • Figure 102. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Prenatal Testing, 2018-2033
      • Figure 103. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other Applications, 2018-2033
      • Figure 104. Latin America Point-of-Care Molecular Diagnostics Market Analysis, By Test Location, 2018, 2022 and 2033
      • Figure 105. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • Figure 106. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by OTC, 2018-2033
      • Figure 107. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by POC, 2018-2033
      • Figure 108. Latin America Point-of-Care Molecular Diagnostics Market Analysis, By End-Use, 2018, 2022 and 2033
      • Figure 109. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • Figure 110. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hospitals, 2018-2033
      • Figure 111. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Home-care, 2018-2033
      • Figure 112. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Decentralized Labs, 2018-2033
      • Figure 113. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Research Institutes, 2018-2033
      • Figure 114. Latin America Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other End-Uses, 2018-2033
      • Figure 115. Latin America Point-of-Care Molecular Diagnostics Market Analysis, By Country, 2018, 2022 and 2033
      • Figure 116. Latin America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 117. Middle East & Africa Point-of-Care Molecular Diagnostics Market Analysis, By Product, 2018, 2022 and 2033
      • Figure 118. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 119. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by PCR-based, 2018-2033
      • Figure 120. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hybridization-based, 2018-2033
      • Figure 121. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Genetic Sequencing-based, 2018-2033
      • Figure 122. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Microarray-based, 2018-2033
      • Figure 123. Middle East & Africa Point-of-Care Molecular Diagnostics Market Analysis, By Application, 2018, 2022 and 2033
      • Figure 124. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 125. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Infectious Diseases, 2018-2033
      • Figure 126. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Oncology, 2018-2033
      • Figure 127. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hematology, 2018-2033
      • Figure 128. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Prenatal Testing, 2018-2033
      • Figure 129. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other Applications, 2018-2033
      • Figure 130. Middle East & Africa Point-of-Care Molecular Diagnostics Market Analysis, By Test Location, 2018, 2022 and 2033
      • Figure 131. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Test Location
      • Figure 132. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by OTC, 2018-2033
      • Figure 133. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by POC, 2018-2033
      • Figure 134. Middle East & Africa Point-of-Care Molecular Diagnostics Market Analysis, By End-Use, 2018, 2022 and 2033
      • Figure 135. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By End-Use
      • Figure 136. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Hospitals, 2018-2033
      • Figure 137. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Home-care, 2018-2033
      • Figure 138. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Decentralized Labs, 2018-2033
      • Figure 139. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Research Institutes, 2018-2033
      • Figure 140. Middle East & Africa Point-of-Care Molecular Diagnostics Market (US$ Bn), by Other End-Uses, 2018-2033
      • Figure 141. Middle East & Africa Point-of-Care Molecular Diagnostics Market Analysis, By Country, 2018, 2022 and 2033
      • Figure 142. Middle East & Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis, By Country
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • QIAGEN AV
    • Bayer AG
    • Nova Biomedical
    • Danaher
    • Nipro Diagnostics
    • Bio-Rad Laboratories Inc.
    • Agilent Technologies Inc.
    • bioMérieux
    • OraSure Technologies
Point-of-Care Molecular Diagnostics Market
Point-of-Care Molecular Diagnostics Market
Published date: Apr 2024
add_shopping_cartBuy Now get_appDownload Sample

Related Reports

Point-of-Care Molecular Diagnostics Market
  • 117982
  • Apr 2024
    • ★★★★★
      ★★★★★
Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo

Our Clients

✖
Request a Sample Report
We'll get back to you as quickly as possible

✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options